This webinar is our humble tribute to India's pioneer HIV researcher Dr Suniti Solomon who had documented first HIV case in the country and made seminal contribution in fighting AIDS on the ground as well. She left for her heavenly abode recently. Her legacy continues to serve the cause, and inspire us. Read what she said to CNS over the recent years, here.

Results of few important studies have come very recently, producing strong evidence to improve treatment outcomes for people with TB-HIV co-infection. For example:

START study was the largest randomized controlled trial ever to see effect of early initiation of antiretroviral therapy (ART). It provided strong evidence that early treatment reduced the risk of the combination of serious AIDS-related illness, serious non-AIDS-related illness and death by more than half compared to deferring treatment. Early treatment reduced the risk of serious AIDS-related and non-AIDS-related illnesses, but had a greater effect on reducing the risk of AIDS-related illnesses. The most common AIDS-related illnesses among study participants were pulmonary tuberculosis, Kaposi’s sarcoma, and non-Hodgkins lymphoma.